Trial Profile
A Retrospective, Single-Centre, Comparative Study of Two Individualized Treatment Regimens with Ranibizumab for Diabetic Macular Edema (DME)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Aug 2017
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 29 Aug 2017 New trial record